Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model

Digestive Diseases and Sciences

Volumn 45, Issue 3, 2000, Pages 500-508

  Alexandrakis, Michael G ^a   Moschandrea, Joanna A ^a   Koulocheri, Stavroula A ^a   Kouroumalis, Elias ^a   Eliopoulos, George D ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Acute phase proteins; Cytokines; Exudate; Peritoneal effusion; Transudate

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; FEMALE; HUMANS; MALE; MATHEMATICS; MIDDLE AGED; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; NEOPLASMS; PROTEINS;

EID: 0034071329     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005437005811     Document Type: Article

References (32)

1. 1. Cascinu S, DelFerro E, Barbanti I, Ligi M, D Fedeli A, Catalano G: Tumor markers in the diagnosis of malignant serous effusions. Am J Clin Oncol 20:247-250, 1997
2. 2. Kountouras J, Boura P, Tsapas G, Charisis K, Magoula I, Tsakiri I: Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites. Anticancer Res 13:2441-2446, 1993
3. 3. Dekker A, Bupp PA: Cytology of serous effusions: An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol 70:855-860, 1978
4. 4. Arbillos A, Cuerras-Mous V, Millan I, Conton T, Montes J, Barrios C, Canido A: Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 98:134-140, 1990
5. 5. Runyon BA, Antillon MR: Ascitic fluid pH and lactate: Insensitive and nonspecific test in detecting ascitic fluid infection. Hepatology 13:929-935, 1991
6. 6. Nystrom JS, Dyce B, Wada J, Bateman JR, Haverback B: Carcinoembryonic antigen titers on effusion fluid. Arch Intern Med 137:875-879, 1977
7. 7. Prieto M, Gomez-Lechon MJ, Hoyos M, Castell JV, Carraso D, Berenguer J: Diagnosis of malignant ascites comparison of ascitic fibronectin, cholesterol and serum ascites albumin difference. Dig Dis Sci 33:833-838, 1988
8. 8. Jungst D, Gerbes AL, Martin R, Paumgartner G: Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Hepatology 6:239-243, 1986
9. 9. Armitage P, Berry G: Statistical Methods in Medical Research, 2nd ed. Oxford, Blackwell Scientific Publications, 1987
10. 10. Everitt BS, Dunn G: Applied Multivariate Data Analysis. London, Edward Arnold, 1991
11. 11. Norusis MJ: SPSS Professional Statistics 6.1, Illinois USA: SPSS Inc, 1994
12. 12. Rice JA: Mathematical Statistics and Data Analysis. California, Wadsworth, Inc., 1988, p. 384
13. 13. Pare P, Talbot J, Hoefs JC: Serum-ascites albumin concentration gradient: A physiologic approach to the differential diagnosis of ascites. Gastroenterology 85:240-244, 1983
14. 14. Rector WG Jr, Reynolds TB: Superiority of the serum-ascites albumin difference over the ascites total protein concentration in separation of transudative and exudative ascites. Am J Med 77:83-85, 1984
15. 15. Yinnon A, Konijn AM, Link G, Moreb J, Hershko C: Diagnostic value of ferritin in malignant pleural and peritoneal effusio ns. Cancer 62:2564-2568, 1988
16. 16. Gerbes AL, Jungst D, Xie Y, Permanetter W, Paumgartner G: Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Cancer 68:1808-1814, 1991
17. 17. Scholmerich J, Volk BA, Kottgen E, Ehlers S, Gerok W: Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites. Gastroenterology 87:1160-1164, 1984
18. 18. Lee CM, Changchien CS, Shyu WC, Liaw YF: Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites. Cancer 70:2057-2060, 1992
19. 19. Colli A, Buccino G, Cocciolo M, Parravicini R, Mariani F, Scaltrini G: Diagnostic accuracy of fibronectin in the differential diagnosis of ascites. Cancer 58:2489-2493, 1986
20. 20. Toussi A, Paquet N, Huber O, Fratiger S, Tissot JD, Hughes GJ, Hochstrasser DF: Polypeptide marker and disease patterns found while mapping proteins in ascitis. J Chromatogr 582:87-92, 1992
21. 1-antitrypsin. Dig Dis Sci 35:1105-1109, 1990
22. 1-antitripsin lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation. Respir Med 91:517-523, 1997
23. 23. Wang SS, Lee FY, Chao Y, Chen CC, Lin HY, Wu SL, Lee SD: Clinical significance of complements in ascitic diseases: Elevated complement levels disapproving the liver disease origin. Proc Natl Sci Counc Repub China B 20:51-57, 1996
24. 24. Schneider D, Halperin R, Langer R, Bilpvslu I, Herman A: Peritoneal fluid lactate dehydrogenase in ovarian cancer. Gynecol Oncol 66:394-399, 1997
25. 25. Pruimboom WM, vanDijk AP, Tak CJ, Bonta IL, Wilson JH, Zijlstra FJ: Production of inflammatory mediators by human macrophages obtained from ascites. Prostaglandins Leukot Essent Fatty Acids 50:183-192, 1994
26. 26. Cappuccini F, Yamamoto RS, Disaia PJ, Grosen EA, Gatanaga M, Lucci JA, Ininus EK, Gatanagos T, Granger GA: Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Lymphokine Cytokine Res 10:225-229, 1991
27. 27. Propst T, Propst A, Herold M, Schauer G, Judmaier G, Braun-steiner H, Stoffler G, Vogel W: Spontaneous bacterial peritonitis is associated with levels of interleukin-6 and its secondary mediators in ascitic fluid. Eur J Clin Invest 23:832-836, 1993
28. 28. Zeni F, Tardy B, Vindimian M, Contet C, Page Y, Cusey I, Bertrand JC: High levels of tumor necrosis factor-α and interleukin-6 in the ascitic fluid of cirrhotic patient with spontaneous bacterial peritonitis. Clin Infect Dis 17:218-223, 1993
29. 29. Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramakrishnan S: Serum and ascitic fluid levels of interleukin-1, interleukin-6 and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 72:2433-2440, 1993
30. 30. Overton C, Fernandez Shaw S, Hicks B, Barlow D, Starkey P: Peritoneal fluid cytokines and the relationship with endometriosis and pain. Hum Reprod 11:380-386, 1996
31. 31. Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Moller E, Daxenbichler G, Offner FA, Dapunt O, Marth C: Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol 16:1861-1868, 1998
32. 32. Mayall F, Heryet A, Manga D, Kriegeskotten A: p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology. Cytopathology 8:9-12, 1997